GDGyulnara O. Dibirova

Gyulnara O. Dibirova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gyulnara O. Dibirova has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Side effects of drugs recommended for the treatment of harmful alcohol use

    by Boris K. Romanov, Gulnara O. Dibirova, Natalia B. Dmitrieva, Elena V. Kalinina, Anna V. Kirillova, Elena V. Markina, Svetlana E. Mileshina, Andrey S. Sokolov, Maia D. Tsitsuashvili, Dmitry E. Yurov, et al.

    This brief report provides an overview of pharmacovigilance information on adverse reactions during post-registration use of medicines recommended for the treatment of mental and behavioral disorders caused by alcohol consumption in the Russian Federation, and its reports were included in the database of the World Health Organizations international drug monitoring program as of January 1, 2023. The safety indicators of benzodiazepines, phenobarbital, butyrophenones, anticonvulsants, thiamine, and magnesium preparations were analyzed. The article may be of interest to pharmacovigilance specialists, doctors, researchers, developers and health regulators, pharmacologists, and clinical pharmacologists.

  • Open Access

    Cardiac rehabilitation and secondary prevention after acute myocardial infarction: a modern view on the problem

    by Elena V. Sayutina, Mikhail A. Osadchuk, Boris K. Romanov, Elena M. Tuaeva, Ludmila I. Butorova, Gyulnara O. Dibirova, Natalya V. Kireeva, Nikolay P. Korzhenkov

    Cardiovascular diseases remain a heavy socioeconomic burden in the modern world, claiming up to four million lives annually, including one million of the Russian population. Most often, cardiovascular mortality is associated with chronic coronary heart disease and its complications. Despite the progress in the treatment of acute coronary syndrome in the acute disease phase, the problem of recurrent coronary events and associated adequate rehabilitation remains unresolved. Modern Russian and European recommendations for cardiovascular rehabilitation present the main directions of secondary prevention of myocardial infarction, which summarize the global and Russian evidence-based medicine data on the problem and are based on the principles of phasing, continuity, succession, and multidisciplinary approach to the patient management. This review focuses on the problems and shortcomings of secondary prevention and cardiac rehabilitation at the patient, doctor, and healthcare system levels. In addition, contemporary approaches to their elimination are described. The necessity and importance of individual training and informing patients and the formation of their sustainable commitment to a healthy lifestyle and therapeutic and preventive measures prescribed by modern guidelines on this issue are emphasized.


  • Open Access

    Biochemical indicators of sports achievements in highly qualified wrestlers

    by S. P. Alpatov, I. V. Konovalov, G. O. Dibirova, E. V. Kalinina, S. E. Mileshina, M. D. Tsitsuashvili, I. A. Zhirova, A. G. Kochetov, S. A. Parastaev

    Objective: to conduct comparative analysis of blood biochemical parameters (urea, ALT, AST, creatinkinase, cortisol, testosterone and testosterone / cortisol ratio) in groups of high­class wrestlers with different levels of sports achievements.Materials and methods: male athletes (n = 78), members of the Russian national team in one of the types of wrestling (the average age is 25.2 (21.5–28.9) years, the average weight is 76.9 (68.4–83.4) kg) were recruited to this study. The examined athletes were divided into two groups according to their sporting achievements. The first one — SHA group (super­high achievements) which included athletes (n = 19) who had victories and prizes at the largest international competitions (European, World, Olympic Games), and the second group — MNT group (members of the national team) which included athletes that did not have similar achievements (n = 59). The following biochemical parameters were studied: urea, creatine kinase, ALT, AST, testosterone, cortisol, anabolic index (AI).Results: the absolute values of all metabolites in the examined athletes were within the reference intervals. Statistically significant differences in most of the biochemical parameters were revealed between the compared groups in terms of the level of sports achievements. The SHA group showed a statistically significant shift in relation to MNT group, in direction of increasing the level of metabolites that characterize the predominance of anabolic processes — ALT, testosterone, AI. Metabolite levels, increase which reflects catabolic processes activity and inadequate or insufficient adaptation processes, in the SHA group were significantly lower than in the MNT group. The above changes of the absolute values of biochemical parameters were confirmed by correlation analysis.Conclusions: the obtained results allow us to state the optimal adaptation of this sport, the adequacy of metabolic processes in the group of highly qualified athletes.


  • Antibiotic treatment failure

    by Sergey P. Alpatov, Nadezhda V. Bogush, Denis A. Borozdenko, Natalia M. Buyanova, Irina V. Ganshina, Gulnara O. Dibirova, Natalia B. Dmitrieva, Elena V. Kalinina, Anna V. Kirillova, Nina M. Kiseleva, et al.

    This review presents information on cases of antibiotic failure (insufficient effect) in the global population over the past three years. We analyzed scientific papers, clinical trial data, and the WHO Program for International Drug Monitoring (VigiBase) data from 2018 to 2020. The values of global success and safety rates of antibacterial drugs for medical use are presented. The findings may be of practical interest to physicians, researchers, developers, and healthcare regulators.

  • Vaccine safety for COVID-19 prevention

    by Boris K. Romanov, Sergey P. Alpatov, Nadezhda V. Bogush, Denis A. Borozdenko, Natalia M. Buyanova, Irina V. Ganshina, Gulnara O. Dibirova, Natalia B. Dmitrieva, Elena V. Kalinina, Anna V. Kirillova, et al.

    BACKGROUND: In 2021, the Uppsala Monitoring Center of the World Health Organization included 52 vaccines for coronavirus disease-2019 (COVID-19) prevention in the international database, VigiBase, and almost immediately, this group of medicines (drugs) took the lead in the increased rate of reported adverse reactions (ARs). AIM: This study aimed to review the case reports of ARs from COVID-19 vaccines in the VigiBase database. MATERIALS AND METHODS: Statistical analysis of cases that describe ARs in the international pharmacovigilance VigiBase database was performed. RESULTS: On May 12, 2021, the VigiBase database included 26,099,906 reports that describe AR cases on drugs, including 585,744 reports of AR on vaccines for COVID-19 prevention. Serious ARs after immunization with these vaccines were registered in 31.5% of reports, including 0.9% fatal and 1.3% life-threatening. Headache (37.1% of reports), pyrexia (31.1%), chills (23.2%), and fatigue (22.7%) were most frequently recorded. CONCLUSIONS: More data are required to confirm the association between the COVID-19 vaccines and the increased risk of ARs following their use.

  • Open Access

    Drug Safety for Children — International Monitoring Data for 50 Years

    by B. K. Romanov, Yu. V. Olefir, R. N. Alyautdin, S. V. Glagolev, V. A. Polivanov, L. I. Ilienko, S. P. Alpatov, N. V. Bogush, N. M. Buyanova, I. V. Ganshina, et al.

    Безопасность применения лекарственных средств у детей — данные международного мониторинга за 50 лет


  • Open Access

    The effect of preventive immunotherapy on indicators of cellular immunity of high-class martial art athletes depending on the level of sporting achievements

    by Sergey P. Alpatov, Gyulnara O. Dibirova, Elena V. Kalinina, Anatoliy G. Kochetov, Ivan V. Konovalov, Elena V. Markina, Andrey V. Polynovskiy, Sergey A. Parastaev